HomeInsightsPE

Gland Pharma Ltd PE Ratio

Gland Pharma Ltd PE Ratio

stocks purchased

₹ 1.8 Cr

Volume Transacted

(Dec 13, 2024)

stocks purchased

10.5 K

Stocks Traded

(Dec 13, 2024)

Last Updated on: Dec 15, 2024

Image

Gland Pharma Ltd

NSE: GLAND

PE

41.6

Last updated on: Dec 15, 2024

Key Highlights

  • The P/E Ratio of Gland Pharma Ltd is 41.6 as of 15 Dec 11:22 AM .
  • The P/E Ratio of Gland Pharma Ltd changed from 40.7 on March 2021 to 39.3 on March 2024 . This represents a CAGR of -0.87% over 4 years.
  • The Latest Trading Price of Gland Pharma Ltd is ₹ 1748 as of 13 Dec 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Gland Pharma Ltd

No data available

Company Fundamentals for Gland Pharma Ltd

No data available

Image

Gland Pharma Ltd

NSE: GLAND

Share Price

₹ 1748.2

-30.40 (-1.71%)

stock direction

Last updated on: Dec 13, 2024

Market Price of Gland Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Gland Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
13 Dec 20241748.2
12 Dec 20241778.6
11 Dec 20241775.35
10 Dec 20241763.45
09 Dec 20241791.6
06 Dec 20241814.1
05 Dec 20241832.6
04 Dec 20241800.4
03 Dec 20241813.75
02 Dec 20241779.4

SWOT Analysis Of Gland Pharma Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Gland Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Gland Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Gland Pharma Ltd4128,801
Sun Pharmaceuticals Industries Ltd384,35,179
Divis Laboratories Ltd851,55,995
Cipla Ltd251,16,890
Torrent Pharmaceuticals Ltd651,13,295
Mankind Pharma Ltd501,05,787

Key Valuation Metric of Gland Pharma Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Gland Pharma Ltd

No data available

* All values are in crore

Historical Revenue of Gland Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Gland Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Gland Pharma Ltd

No data available

* All values are in crore

Historical Dividend Payout of Gland Pharma Ltd

No data available

* All values are in %

About Gland Pharma Ltd

  • Gland Pharma Ltd was incorporated as Gland Pharma Private Limited', a private limited company under the Companies Act, 1956 on March 20, 1978 and was granted the certificate of incorporation by Registrar of Companies, Andhra Pradesh at Hyderabad.
  • Subsequently, the name of the Company was changed to Gland Pharma Limited' pursuant to a special resolution passed by the shareholders of the Company on December 5, 1994 and a fresh certificate of incorporation dated April 25, 1995 was issued by the Registrar of Companies, Andhra Pradesh at Hyderabad consequent upon change of name and conversion into a public limited company under the Companies Act, 1956.
  • The Company is primarily engaged in manufacturing injectable formulations. The company is one of the fastest growing generic injectables-focused companies by revenue in the United States from 2014 to 2019.

Gland Pharma Ltd News Hub

News

Gland Pharma slides after Q1 PAT slumps 26% YoY to Rs 144 cr

Revenue from operations jumped 15.97% YoY to Rs 1,401.70 crore in Q1 FY25. Profit before t...

Read more

2024-08-07 00:00:00

News

Gland Pharma consolidated net profit declines 25.94% in the June 2024 quarter

Net profit of Gland Pharma declined 25.94% to Rs 143.76 crore in the quarter ended June 20...

Read more

2024-08-06 00:00:00

News

US FDA issues 3 Form 483 observations to Gland Pharma's Pashamylaram facility

The said inspection was conducted between 25 July 2024 and 02 August 2024. The said inspec...

Read more

2024-08-05 00:00:00

News

Gland Pharma Ltd gains for third straight session

Gland Pharma Ltd gained for a third straight session today. The stock is quoting at Rs 193...

Read more

2024-09-09 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Gland Pharma Ltd

What is the current PE Ratio of Gland Pharma Ltd?

The Current PE Ratio of Gland Pharma Ltd is 41.64 as on 15 Dec 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 15 Dec 2024.

What was the PE Ratio of Gland Pharma Ltd last year?

The PE Ratio of Gland Pharma Ltd was 26.75 last year, now the PE ratio is 41.64, showing a year-on-year growth of 55.7%.

What does the PE Ratio of Gland Pharma Ltd indicate about its stock?

The PE Ratio of Gland Pharma Ltd is 41.64. This ratio indicates that investors are willing to pay 41.64 times the earnings per share for each share of Gland Pharma Ltd.

What is the PE Ratio Growth of Gland Pharma Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Gland Pharma Ltd grew by 55.7% whereas, the EPS ratio grew by 13.7.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions